Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Acacetin is an O-methylated flavone, a type of flavonoid, which are naturally occurring plant pigments. It is found in various plants and has been used as an active component in traditional Chinese medicine, specifically in Xuelianhua. Acacetin is a yellow solid and has been reported to exhibit spasmolytic, antinociceptive, anti-inflammatory, and antioxidant activities in various research models.

480-44-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 480-44-4 Structure
  • Basic information

    1. Product Name: Acacetin
    2. Synonyms: 2-(4-Methoxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one;LY 064233;NSC 76061;ACACETIN >= 97.0% (HPLC);5,7-dihydroxy-2-(4-methoxyphenyl)-4h-1-benzopyran-4-on;5,7-dihydroxy-4’-methoxy-flavon;5,7-dioxy-4’-methoxyflavone;acacetine
    3. CAS NO:480-44-4
    4. Molecular Formula: C16H12O5
    5. Molecular Weight: 284.26
    6. EINECS: 207-552-3
    7. Product Categories: chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;inhibitor;Tri-substituted Flavones;Aromatics;Heterocycles;Miscellaneous Reagents
    8. Mol File: 480-44-4.mol
  • Chemical Properties

    1. Melting Point: 260-265 °C(lit.)
    2. Boiling Point: 346.76°C (rough estimate)
    3. Flash Point: 198.2 °C
    4. Appearance: Pale-yellow needles
    5. Density: 1.2160 (rough estimate)
    6. Vapor Pressure: 2.25E-11mmHg at 25°C
    7. Refractive Index: 1.6200 (estimate)
    8. Storage Temp.: 2-8°C
    9. Solubility: DMSO (Slightly), Methanol (Very Slightly, Heated)
    10. PKA: 6.51±0.40(Predicted)
    11. Merck: 14,13
    12. BRN: 277879
    13. CAS DataBase Reference: Acacetin(CAS DataBase Reference)
    14. NIST Chemistry Reference: Acacetin(480-44-4)
    15. EPA Substance Registry System: Acacetin(480-44-4)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-36
    4. WGK Germany: 3
    5. RTECS: DJ3002000
    6. F: 3-8-10
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 480-44-4(Hazardous Substances Data)

480-44-4 Usage

Uses

Used in Pharmaceutical Industry:
Acacetin is used as a bioactive compound for its various pharmacological properties, including spasmolytic, antinociceptive, anti-inflammatory, and antioxidant activities. These properties make it a potential candidate for the development of new drugs and therapies.
Used in Anticancer Applications:
Acacetin is used as a VEGF expression inhibitor and tumor angiogenesis inhibitor. Its flavonoid nature provides antiaggregatory activity in human blood, which can be beneficial in the prevention and treatment of cancer.
Used in Traditional Chinese Medicine:
Acacetin is used as an active component in the traditional Chinese medicine Xuelianhua, where it contributes to the overall therapeutic effects of the herbal preparation.
Used in Research and Development:
Acacetin is used as a research compound for studying its potential applications in various fields, including pharmacology, medicine, and biotechnology. Its diverse biological activities make it an interesting subject for further investigation and potential drug development.

Synthesis Reference(s)

Tetrahedron Letters, 31, p. 6497, 1990 DOI: 10.1016/S0040-4039(00)97100-4

Biochem/physiol Actions

Acacetin has been noted to exhibit anti-peroxidative, anti-inflammatory, and anti-plasmodial properties. It has been posited to prevent the proliferation of Hep G2 cells, thereby causing cell apoptosis and subsequent anti-cancer action. It has antiarrhythmic properties and can be used in the treatment of Atrial fibrillation.

Enzyme inhibitor

This naturally occurring flavone (FW = 286.27 g/mol; CAS 480-44-4), also known as 5,7-dihydroxy-4’-methoxyflavone and 7-O-methylapigenin, and systematically named as 5,7-dihydroxy-2-(4-methoxyphenyl)-chromen-4- one, from the black locust Robinia pseudoacacia is the aglycon of linarin and acaciin and is biosynthesized by apigenin 4'-O-methyltransferase from S-adenosyl-methionine and 5,7,4’-trihydroxyflavone (apigenin), yielding Sadenosylhomocysteine and acacetin. The chemical synthesis of acacetin was accomplished by Robert Robinson, who was awarded the 1947 Nobel Prize in Chemistry for his work on alkaloids and organic synthesis. Target(s): glutathione S-transferase; xanthine oxidase, Ki = 0.11 μM; CYP1A; CYP1B1; glutathione-disulfide reductase; DNA topoisomerase I; [myosin light-chain] kinase; and protein-tyrosine kinase, or non-specific protein-tyrosine kinase.

Check Digit Verification of cas no

The CAS Registry Mumber 480-44-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,8 and 0 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 480-44:
(5*4)+(4*8)+(3*0)+(2*4)+(1*4)=64
64 % 10 = 4
So 480-44-4 is a valid CAS Registry Number.
InChI:InChI=1/C16H12O5/c1-20-11-4-2-9(3-5-11)14-8-13(19)16-12(18)6-10(17)7-15(16)21-14/h2-8,17-18H,1H3

480-44-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Acacetin

1.2 Other means of identification

Product number -
Other names 5,7-dihydroxy-4'-methoxyflavone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:480-44-4 SDS

480-44-4Synthetic route

acacetin diacetate
5892-39-7

acacetin diacetate

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With sodium methylate In methanol at 20℃; for 1h;100%
1-<2-hydroxy-4,6-bis(methoxymethoxy)phenyl>-3-(4-methoxyphenyl)propane-1,3-dione

1-<2-hydroxy-4,6-bis(methoxymethoxy)phenyl>-3-(4-methoxyphenyl)propane-1,3-dione

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With Amberlyst 15 resin In isopropyl alcohol for 4h; Heating;96%
5-hydroxy-4'-methoxy-7-[(2-O-α-L-rhamnopyranosyl-β-D-glucopyranosyl)oxy]flavone
20633-93-6

5-hydroxy-4'-methoxy-7-[(2-O-α-L-rhamnopyranosyl-β-D-glucopyranosyl)oxy]flavone

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With ethanol; sulfuric acid for 2h; Reflux;87%
3,5-dihydroxyphenol
108-73-6

3,5-dihydroxyphenol

ethyl 4-methoxybenzoylacetate
2881-83-6

ethyl 4-methoxybenzoylacetate

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
for 0.0583333h; microwave irradiation;81%
With dmap at 200℃; for 3h; Reagent/catalyst; Inert atmosphere;71%
5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
520-36-5

5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one

methyl iodide
74-88-4

methyl iodide

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 18h; Inert atmosphere; regiospecific reaction;79%
With potassium carbonate In N,N-dimethyl-formamide for 2h;
4,6-bis(methoxymethyl)-2-(4-methoxylbenzoyloxy)acetophenone

4,6-bis(methoxymethyl)-2-(4-methoxylbenzoyloxy)acetophenone

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
Stage #1: 4,6-bis(methoxymethyl)-2-(4-methoxylbenzoyloxy)acetophenone With potassium hydroxide In pyridine at 50℃; for 0.333333h;
Stage #2: With acetic acid In pyridine; water for 0.5h;
Stage #3: With hydrogenchloride In methanol Reflux;
75%
2,4,6-trihydroxyacetophenone
480-66-0

2,4,6-trihydroxyacetophenone

4-methoxy-benzoyl chloride
100-07-2

4-methoxy-benzoyl chloride

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With potassium carbonate In acetone at 65℃; for 24h; Inert atmosphere;72%
Stage #1: 2,4,6-trihydroxyacetophenone With potassium carbonate In acetone at 20℃; for 0.166667h; Inert atmosphere;
Stage #2: 4-methoxy-benzoyl chloride In acetone at 60℃; for 24h; Inert atmosphere;
71%
Stage #1: 2,4,6-trihydroxyacetophenone With potassium carbonate In acetone at 20℃; for 0.166667h;
Stage #2: 4-methoxy-benzoyl chloride In acetone for 24h; Heating;
45%
Stage #1: 2,4,6-trihydroxyacetophenone; 4-methoxy-benzoyl chloride With potassium carbonate In pyridine at 120℃; for 3h; Heating / reflux;
Stage #2: With potassium hydroxide; water In methanol for 20h; Heating / reflux;
Stage #3: With acetic acid In water pH=9;
Stage #1: 2,4,6-trihydroxyacetophenone; 4-methoxy-benzoyl chloride With pyridine; 1,8-diazabicyclo[5.4.0]undec-7-ene for 8h; Reflux;
Stage #2: With sodium hydroxide In 1,4-dioxane; methanol
C32H24O9
110865-07-1

C32H24O9

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With sodium methylate In ethanol; dichloromethane70%
acacetin 7-O-rutinoside
480-36-4

acacetin 7-O-rutinoside

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With hydrogenchloride at 50 - 55℃; for 1.5h;70%
7-benzyl-3'-phenyltetrazolyldiosmetin
771481-08-4

7-benzyl-3'-phenyltetrazolyldiosmetin

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With ammonium formate; palladium on activated charcoal In methanol for 2.5h; Heating;68%
4',5,7-trimethoxyflavone
5631-70-9

4',5,7-trimethoxyflavone

A

5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
520-36-5

5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one

B

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With N-butyl-N-methylimidazolium heptachlorodialuminate In dichloromethane at 40℃; for 4h;A 54%
B 16%
dimethyl sulfate
77-78-1

dimethyl sulfate

rhoifolin
17306-46-6

rhoifolin

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
Stage #1: dimethyl sulfate; rhoifolin With sodium hydroxide In water at 10 - 25℃; for 6h;
Stage #2: With sulfuric acid In water for 8h; Reflux;
32.31%
acacetin 7-O-β-D-galactopyranoside
80443-15-8, 4291-60-5

acacetin 7-O-β-D-galactopyranoside

A

D-Galactose
10257-28-0

D-Galactose

B

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With hydrogenchloride In ethanol for 2h; on steam bath;A n/a
B 18%
2-chloro-1-(2,4,6-trihydroxyphenyl)ethan-1-one
110865-03-7

2-chloro-1-(2,4,6-trihydroxyphenyl)ethan-1-one

4-methoxy-benzaldehyde
123-11-5

4-methoxy-benzaldehyde

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
Stage #1: 2-chloro-1-(2,4,6-trihydroxyphenyl)ethan-1-one; 4-methoxy-benzaldehyde With potassium hydroxide In ethanol at 20℃; for 3h;
Stage #2: With hydrogenchloride In ethanol; water at 55℃; for 1h;
17.8%
3,5-dihydroxyphenol
108-73-6

3,5-dihydroxyphenol

methyl 3-(4-methoxybenzoyl)acetate
22027-50-5

methyl 3-(4-methoxybenzoyl)acetate

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
at 250℃;
5,7-dihydroxy-2-(4-methoxyphenyl)chroman-4-one
480-43-3, 26207-61-4, 65337-52-2

5,7-dihydroxy-2-(4-methoxyphenyl)chroman-4-one

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With ethanol; iodine; sodium acetate
5,7-diacetoxy-2-(4-methoxy-phenyl)-chroman-4-one
117894-08-3

5,7-diacetoxy-2-(4-methoxy-phenyl)-chroman-4-one

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With chloroform; bromine Irradiation.Erwaermen des Reaktionsprodukts mit wss.-aethanol. Natronlauge;
2,4,6-trihydroxyacetophenone
480-66-0

2,4,6-trihydroxyacetophenone

p-Methoxybenzoic anhydride
794-94-5

p-Methoxybenzoic anhydride

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With sodium anisate Verseifen des Reaktionsprodukts mit alkoholisch-waessriger-Kalilauge;
5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
520-36-5

5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one

A

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

B

5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4H-chromen-4-one
5128-44-9

5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4H-chromen-4-one

Conditions
ConditionsYield
With O-methyl transferase from cell-free extract of Citrus mitis; <(14)CH3>-S-adenosyl-L-methionine; 2-hydroxyethanethiol In water; dimethyl sulfoxide at 35℃; for 0.5h; Product distribution; pH 7.5 buffer;
1-(4-Methoxy-phenyl)-3-(2,4,6-trihydroxy-phenyl)-propane-1,3-dione
99474-26-7

1-(4-Methoxy-phenyl)-3-(2,4,6-trihydroxy-phenyl)-propane-1,3-dione

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With potassium carbonate; acetic acid 1.) reflux, 4 h, 2.) 5 min; Yield given;
With sulfuric acid In acetic acid at 95 - 100℃; Yield given;
With sulfuric acid; acetic acid at 100℃; for 1h; Yield given;
C32H26O10
80443-16-9

C32H26O10

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With sodium acetate In acetic acid for 3h; Heating;
isosakuranetin 7-O-rhamnoside

isosakuranetin 7-O-rhamnoside

A

6-deoxy-β-D-mannopyranose
28161-50-4

6-deoxy-β-D-mannopyranose

B

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With hydrogenchloride at 100℃; for 3h;
acacetin-7-O-<β-D-glucopyranosyl(1->4)-α-D-xylopyranoside>

acacetin-7-O-<β-D-glucopyranosyl(1->4)-α-D-xylopyranoside>

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With sulfuric acid at 100℃; for 2h;
acaciin

acaciin

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With sulfuric acid
apiin methyl ether

apiin methyl ether

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With hydrogenchloride
linarin

linarin

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
With hydrogenchloride
3'-O-(1-phenyltetrazol-5-yl)diosmin
771480-96-7

3'-O-(1-phenyltetrazol-5-yl)diosmin

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 53 percent / HCOONH4 / Pd/C / methanol / 5 h / Heating
2: 70 percent / aq. HCl / 1.5 h / 50 - 55 °C
View Scheme
diosmetin
520-34-3

diosmetin

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 66 percent / KHCO3 / dimethylformamide / 2.5 h / 120 °C
2: 67 percent / KHCO3 / dimethylformamide / 1 h / 120 °C
3: 68 percent / HCOONH4 / Pd/C / methanol / 2.5 h / Heating
View Scheme
diosmin
520-27-4

diosmin

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 40 percent / KHCO3 / dimethylformamide / 2 h / 80 °C
2: 53 percent / HCOONH4 / Pd/C / methanol / 5 h / Heating
3: 70 percent / aq. HCl / 1.5 h / 50 - 55 °C
View Scheme
5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

methyl iodide
74-88-4

methyl iodide

5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4H-chromen-4-one
5128-44-9

5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4H-chromen-4-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃;95%
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 18h; Inert atmosphere; regiospecific reaction;73%
In pyridine at 20℃; for 2h;
5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

benzenesulfonyl chloride
1939-99-7

benzenesulfonyl chloride

7-benzylsulfonylacacetin

7-benzylsulfonylacacetin

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 20℃; for 0.5h;94%
5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

C16H10Br2O5

C16H10Br2O5

Conditions
ConditionsYield
With N-Bromosuccinimide In trifluoroacetic acid at 20℃; for 5h;94%
methyl 6-bromohexanoate
14273-90-6

methyl 6-bromohexanoate

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

methyl 6-((5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl)oxy)hexanoate

methyl 6-((5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl)oxy)hexanoate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 70℃; for 6h; Inert atmosphere;89%
5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Hexanoyl chloride
142-61-0

Hexanoyl chloride

5,7-di-O-hexanoyl-acacetin

5,7-di-O-hexanoyl-acacetin

Conditions
ConditionsYield
With dmap; triethylamine In N,N-dimethyl-formamide at 20℃; for 4.5h; Cooling with ice;87%
With dmap; triethylamine In N,N-dimethyl-formamide
methyl 8-bromooctanoate
26825-92-3

methyl 8-bromooctanoate

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

methyl 8-((5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl)oxy)octanoate

methyl 8-((5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl)oxy)octanoate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 70℃; for 6h; Inert atmosphere;87%
5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

propargyl bromide
106-96-7

propargyl bromide

7-O-propargylacacetin

7-O-propargylacacetin

Conditions
ConditionsYield
With potassium carbonate In acetone for 2h; Reflux;85%
ethyl 7-bromoheptanoate
29823-18-5

ethyl 7-bromoheptanoate

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

ethyl 7-((5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl)oxy)heptanoate

ethyl 7-((5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl)oxy)heptanoate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 70℃; for 6h; Inert atmosphere;84%
5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

(2R,3R,4S,5R,6S)-2-(acetoxymethyl)-6-((5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate
1389307-17-8

(2R,3R,4S,5R,6S)-2-(acetoxymethyl)-6-((5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate

Conditions
ConditionsYield
With tetrabutylammomium bromide; potassium carbonate In chloroform at 45℃; for 12h; Inert atmosphere; regioselective reaction;83%
With tetrabutylammomium bromide; potassium carbonate In chloroform at 45℃; for 12h;83.11%
1-(chloromethyl)-2,4-dimethoxybenzene
55791-52-1

1-(chloromethyl)-2,4-dimethoxybenzene

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

C35H34O8

C35H34O8

Conditions
ConditionsYield
With triethylamine In dichloromethane at 110 - 120℃; for 8h; Inert atmosphere;82.07%
n-octadecyl p-toluenesulfonate
3386-32-1

n-octadecyl p-toluenesulfonate

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

C52H84O5

C52H84O5

Conditions
ConditionsYield
With sodium carbonate In benzene at 20 - 130℃; for 8h;80.28%
C14H19FO9
126641-47-2

C14H19FO9

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

5-hydroxy-4'-methoxyflavone 7-O-β-D-galactopyranoside tetraacetate
80443-10-3

5-hydroxy-4'-methoxyflavone 7-O-β-D-galactopyranoside tetraacetate

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In dichloromethane at -20 - -5℃; for 3.5h; Molecular sieve; Inert atmosphere; stereoselective reaction;78%
5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

2,3,4,6-tetra-O-acetyl-β-galactopyranosyl fluoride
4163-45-5

2,3,4,6-tetra-O-acetyl-β-galactopyranosyl fluoride

5-hydroxy-4'-methoxyflavone 7-O-β-D-galactopyranoside tetraacetate
80443-10-3

5-hydroxy-4'-methoxyflavone 7-O-β-D-galactopyranoside tetraacetate

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In dichloromethane at -20 - -5℃; Inert atmosphere; stereoselective reaction;78%
5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

Dibenzyl N,N-diisopropylphosphoramidite
108549-23-1

Dibenzyl N,N-diisopropylphosphoramidite

C30H25O8P

C30H25O8P

Conditions
ConditionsYield
Stage #1: 5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one; Dibenzyl N,N-diisopropylphosphoramidite With 1H-tetrazole In acetonitrile at 20℃; for 12h;
Stage #2: With tert.-butylhydroperoxide In acetonitrile at 20℃; for 0.0833333h;
76%
1-bromo-2,3,4,6-tetra-O-acetyl-D-galactopyranose
3068-32-4

1-bromo-2,3,4,6-tetra-O-acetyl-D-galactopyranose

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

5-hydroxy-4'-methoxyflavone 7-O-β-D-galactopyranoside tetraacetate
80443-10-3

5-hydroxy-4'-methoxyflavone 7-O-β-D-galactopyranoside tetraacetate

Conditions
ConditionsYield
With tetrabutylammomium bromide; potassium carbonate In chloroform at 45℃; for 12h; Inert atmosphere; regioselective reaction;75%
[13C]methyl iodide
4227-95-6

[13C]methyl iodide

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

13C-4’,12C-7-methylapigenenin

13C-4’,12C-7-methylapigenenin

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 18h; Inert atmosphere; regiospecific reaction;73%
Conditions
ConditionsYield
With tetrabutylammomium bromide; potassium carbonate In chloroform at 45℃; for 12h; Inert atmosphere; regioselective reaction;71%
α-hepta-O-acetyllactosyl bromide

α-hepta-O-acetyllactosyl bromide

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

acacetin-7-O-β-D-hepta-O-acetyllactoside
1389307-18-9

acacetin-7-O-β-D-hepta-O-acetyllactoside

Conditions
ConditionsYield
With tetrabutylammomium bromide; potassium carbonate In chloroform at 45℃; for 12h; Inert atmosphere; regioselective reaction;65%
5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one
480-44-4

5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one

N-(3-bromopropyl)propane-1-sulfonamide

N-(3-bromopropyl)propane-1-sulfonamide

N-{3-[5,7-dihydroxy-2-(4-methoxyphenyl)-4-oxochroman-3-yl]propyl}propane-1-sulfonamide

N-{3-[5,7-dihydroxy-2-(4-methoxyphenyl)-4-oxochroman-3-yl]propyl}propane-1-sulfonamide

Conditions
ConditionsYield
Stage #1: N-(3-bromopropyl)propane-1-sulfonamide With magnesium In tetrahydrofuran Heating;
Stage #2: 5,7-dihydroxy-2-(4'-methoxyphenyl)-4H-1-benzopyran-4-one With zirconocene dichloride In tetrahydrofuran at 30 - 40℃; for 2h;
65%

480-44-4Relevant articles and documents

Structure determination and quantification of a new flavone glycoside with anti-acetylcholinesterase activity from the herbs of Elsholtzia ciliata

Nugroho, Agung,Park, Jong-Hyuk,Choi, Jae Sue,Park, Kyoung-Sik,Hong, Joon-Pyo,Park, Hee-Juhn

, p. 1 - 8 (2017)

Three acacetin triglycosides (compounds 1, 2 and 3) were isolated from the herbs of Elsholtzia ciliata (Labiatae). The structure were identified as 7-O-β-D-glucopyranosyl-(1?→?2)[α-L-rhamnopyranosyl-(1?→?6)]-β-D-glucopyranoside (compound 1), 7-O-(6-O-acetyl)-β-D-glucopyranosyl-(1?→?2)[α-L-rhamnopyranosyl-(1?→?6)]-β-D-glucopyranoside (compound 2) and 7-O-(6-O-acetyl)-β-D-glucopyranosyl-(1?→?2)[(4-O-acetyl)-α-L-rhamnopyranosyl-(1?→?6)]-β-D-glucopyranoside (compound 3) of acacetin. The structures of these compounds were determined on the basis of 2D-NMR spectroscopic data. Compound 3 has not been isolated from a natural source. In addition, the three compounds were quantitatively analysed by HPLC. Acetylcholinesterase (AChE) inhibition activity was assayed to find anti-Alzheimer’s activity, since this enzyme increases the concentration of acetylcholine (ACh), a neurotransmitter, responsible for brain’s memory. Acacetin, the aglycone of the three compounds, exhibited a potent anti-cholinesterase activity (IC50, 50.33?±?0.87), though its glycosides (1, 2 and 3) were less active. HPLC analysis demonstrated that the three compounds were contained in the MeOH extract in the order of compounds 2 (12.63?mg/g extract) > 3 (3.10?mg/g) > 1 (2.92?mg/g).

Anti-inflammatory activity of flavonoids from Chrozophora tinctoria

Abdallah, Hossam M.,Almowallad, Fahad M.,Esmat, Ahmed,Shehata, Ibrahim A.,Abdel-Sattar, Essam A.

, p. 74 - 80 (2015)

Abstract Chemical investigation of Chrozophora tinctoria (L.) A. Juss. growing in Saudi Arabia revealed the isolation of two new acylated flavonoids identified as acacetin-7-O-β-d-[α-l-rhamnosyl(1 → 6)]3″-E-p-coumaroyl glucopyranoside (4) and apigenin-7-O-(6″-Z-p-coumaroyl)-β-d-glucopyranoside (5), in addition to amentoflavone (1), apigenin-7-O-β-d-glucopyranoside (2), apigenin-7-O-6″-E-p-coumaroyl-β-d-glucopyranoside (3) and rutin (6). The structures of isolated compounds were established by 1D, 2D NMR and HRESIMS spectral data, in addition to comparison with literature data. The anti-inflammatory activities of isolated compounds were assessed by measuring the levels of IL-1β, IL-6, TNF-α and PGE2 in the supernatant media of human peripheral blood mononuclear cells (PBMCs) stimulated by phytohaemagglutinin (PHA). At a concentration of 100 μM, compounds 1, 2, 4 and 6 significantly decreased Il-1β, Il-6 and PGE2 to nearly normal values. All tested compounds caused a dose-dependent decrease in TNF-α level but failed to reach that of the control values.

New C,O-Glycosylflavones from the Genus Silene

Olennikov,Kashchenko

, p. 1026 - 1034 (2020/11/05)

Chromatographic separation of extracts from the aerial parts of three Silene species (Caryophyllaceae) isolated 26 flavonoids including the four new C,O-glycosylflavones acacetin-6-C-(2″-O-β-D-glucopyranosyl)-β-D-glucopyranoside-7-O-β-D-glucopyranoside (s

Preparation method of acacetin

-

Page/Page column 7-11, (2019/04/26)

The invention provides a preparation method of acacetin, and solves the problems that a reagent for a conventional chemical synthesis is complex, high in toxicity, unfriendly to environment, severe inreaction condition, and unsuitable for large-scaled industrial production. The preparation method comprises the steps of selecting dihydro myricitrin as an initial raw material, and hydrolyzing the dihydro myricitrin under alkaline environment to obtain a hydroxyacetophenone intermediate; performing a catalyzing cyclization reaction on the hydroxyacetophenone and p-anisaldehyde to obtain a flavonol intermediate; and reducing the flavonol intermediate to obtain an acacetin crude product, and finally, performing refining to obtain acacetin quality products in which the content of a liquid phaseis 98% or above. The technology is low in cost, high in yield, simple in reaction condition, simple and safe to operate, economical and practical, environmental-friendly and pollution-free, the product quality meets market requirements, and the reagent is suitable for large-scale industrial production.

Site-selective synthesis of acacetin and genkwanin through lipase-catalyzed deacetylation of apigenin 5,7-diacetate and subsequent methylation

Fujita, Rie,Hanaya, Kengo,Higashibayashi, Shuhei,Mandal, Susanta,Shoji, Mitsuru,Sugai, Takeshi

, p. 638 - 648 (2019/07/31)

Candida antarctica lipase B-catalyzed deacetylation proceeded with high site-selectivity on the C-4′ acetyl group in apigenin triacetate to give apigenin 5,7-diacetate. Methylation of the liberated hydroxy group with the combination of trimethyloxonium tetrafluoroborate (Meerwein reagent) and 1,8-bis(dimethylamino)naphthalene (proton sponge) in CH2Cl2 proceeded in a quantitative manner to give the product methylated at the C-4′ hydroxy group (acacetin 5,7-diacetate). Even with the same precursor, a different methylation product at the C-7 hydroxy group (genkwanin 4′,5-diacetate) was obtained in 86% yield by applying iodomethane and Cs2CO3 in dimethyl sulfoxide (DMSO). The methylated products were deprotected to form acacetin and genkwanin. We inferred that the latter unexpected methylation was ascribable to the intermolecular migration of an acetyl group from C-7 to C-4′. DFT calculations indicated that the C-7 phenoxide ion was 12.6 kJ/mol more stable than the initially formed C-4′ phenoxide ion.

The invention relates to a raw material to synthesize the tin setose thistle glucoside naringin method (by machine translation)

-

, (2018/11/22)

The invention discloses a to naringin as raw material synthetic tin setose thistle glucoside method, comprises the following steps: S1, synthesis of wild lacquer tree glucoside; S2, compound 5, 7 - dihydroxy - 2 - (4 - methoxyphenyl) - 4 H - chromen - 4 - one synthesis; acetoxy methyl) - 6 - ((5 - hydroxy - 2 - (4 - methoxyphenyl) - 4 - oxo - 4 H - chromen - 7 - yl) oxy) tetrahydro - 2 H - pyran - 3, 4, 5 - [...] acetate synthesis; S4, compound 5 - hydroxy - 2 - (4 - methoxyphenyl) - 7 - (( (2 S, 3 R, 4 S, 5 S, 6 R) - 3, 4, 5 - trihydroxy - 6 - (hydroxymethyl) tetrahydro - 2 H - pyran - 2 - Kiki) oxy) - 4 H - benzopyran - 4 - one synthesis. The invention to naringin as raw materials, by oxidation, methylation, hydrolysis reaction to synthesize tian jigan. (by machine translation)

Encoding matter with regiospecific 12C/13C isotopic labels

La Clair, James J.

supporting information, p. 2611 - 2614 (2018/03/21)

Society suffers due to an inability to regulate matter. This study presents a practical tool for the encryption of materials by adjusting the levels of 13C at regiospecific atoms within a molecule to generate a stable-isotopically encoded signature. This system is demonstrated by securing a document by adapting natural product chemistry as an encryption device. This approach delivers a complex signal that would be difficult to intercept due to the need for access to extraction protocols, sophisticated NMR instrumentation and a vital level of prior knowledge. Overall, this discovery offers an important tool to monitor and track valuable entities on our planet.

Structure-activity relationship of the inhibitory effects of flavonoids on nitric oxide production in RAW264.7 cells

Jiang, Wen-Jun,Daikonya, Akihiro,Ohkawara, Mitsuyoshi,Nemoto, Takashi,Noritake, Ryusuke,Takamiya, Tomoko,Kitanaka, Susumu,Iijima, Hiroshi

, p. 1 - 5 (2016/12/30)

We isolated flavonoids from herbal specimens from the Tibetan region (Sophora yunnanensis and Rhodiola sacra) that suppress nitric oxide (NO) production in macrophages stimulated by lipopolysaccharide and interferon-γ. The isolated flavonoids carry symmetric substitutions in the B ring (R3′= R5′). We analyzed the quantitative structure-activity relationship of the inhibitory activity by comparative molecular field analysis (CoMFA) using this series of flavonoids. Use of flavonoids with symmetrical substitutions in the B ring made it simpler to align molecules because it was not necessary to consider a huge number of combinations due to the B-ring conformation. The CoMFA model, whose cross-validated q2value was 0.705, suggested the existence of a hydroxy group at the 5-position, the choice of the A/C-ring scaffold (chromane or chromene) and electrostatic field around the B ring are important for NO inhibitory activity. Flavonoids synthesized based on the CoMFA model exhibited significant inhibitory potential against NO production, validating the predictive capability of the CoMFA model.

Lysionotin preparation method

-

, (2017/09/05)

The invention provides a lysionotin preparation method. The lysionotin preparation method is characterized by including preparation steps: step one, adopting phloroglucinol and acetic anhydride as reaction materials, and performing Friedel-Crafts reaction under catalysis of boron trifluoride diethyl etherate to obtain 2,4,6-trihydroxyacetophone; step two, subjecting 2,4,6-trihydroxyacetophone obtained at the step one to annulation reaction with p-anisoyl chloride under catalysis of potassium carbonate to obtain 5,7-dyhydroxy-4'-methoxyflavone; step three, subjecting 5,7-dyhydroxy-4'-methoxyflavone to free radical reaction under catalysis of NBS to obtain 5,7-dyhydroxy-6,8-dibromo-4'-methoxyflavone; step four, subjecting 5,7-dyhydroxy-6,8-dibromo-4'-methoxyflavone obtained at the step three to methoxylation reaction with sodium methylate under catalysis of cuprous bromide to obtain lysionotin.

Synthesis of acacetin and resveratrol 3,5-di-O-β-glucopyranoside using lipase-catalyzed regioselective deacetylation of polyphenol glycoside peracetates as the key step

Hanamura, Shun,Hanaya, Kengo,Shoji, Mitsuru,Sugai, Takeshi

, p. 19 - 26 (2016/03/30)

Acacetin and resveratrol 3,5-di-O-β-glucopyranoside were synthesized from naturally abundant naringin and piceid in 65% and 62% overall yield, respectively. The key steps were the regioselective deacetylation of the peracetates of the glycosylated forms with Candida antarctica lipase B (Novozym 435) and Burkholderia cepacia lipase (Amano PS-IM). Deacetylation occurred exclusively at the least hindered position of the aromatic moieties and all acetyl groups in the sugar side chain remained intact. This excellent selectivity enabled regiospecific transformation of the liberated phenolic hydroxy groups, resulting in efficient synthesis of the target molecules.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 480-44-4